Navigation Links
Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant
Date:1/7/2011

ectual property assets; market acceptance of our future products; government regulation of the pharmaceutical industry; our dependence on a small number of products; our dependence on outside manufacturers for the manufacture of most of our products; our dependence on third parties to supply raw materials and to provide services for certain core aspects of our business; new regulatory action or lawsuits relating to our use of narcotics in most of our core products; our exposure to product liability claims and product recalls and the possibility that we may not be able to adequately insure ourselves; our ability to protect our proprietary technology; the successful efforts of manufacturers of branded pharmaceuticals to use litigation and legislative and regulatory efforts to limit the use of generics and certain other products; our ability to successfully implement our acquisition and in-licensing strategy; regulatory or other limits on the availability of controlled substances that constitute the active ingredients of some of our products and products in development; the availability of third-party reimbursement for our products; the outcome of any pending or future litigation or claims by third parties or the government, and the performance of indemnitors with respect to claims for which we have the right to be indemnified; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of our total revenues; significant litigation expenses to defend or assert patent infringement claims; any interruption or failure by our suppliers, distributors and collaboration partners to meet their obligations pursuant to various agreements with us; a determination by a regulatory agency that we are engaging or have engaged in inappropriate sales or marketing activities, including promoting the "off-label" use of our products; existing suppliers become unavailable or lose their regulatory status as an approved source, cau
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... leading OTC brands from GSK in an all cash ... clear demonstration of Perrigo,s unique ability to maximize brand ... 36 countries.  Perrigo Chairman, President and ... excited to complete this transaction, which clearly demonstrates our ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... CUPERTINO, Calif. , Aug. 27, 2015 ... management is scheduled to present at three upcoming healthcare ... , President and CEO, will present at the Rodman ... 10:00 a.m. Eastern time. The conference is being held ... York City . A live audio webcast of ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
... THE WOODLANDS, Texas, Dec. 7, 2010 Community-based oncology practices ... iKnowMed PM. iKnowMed PM is offered by US Oncology, ... accessible via the Internet and customizable for community-based oncology practices. ... and can interface with a variety of other EHRs already ...
... Dec. 7, 2010 MedAvante, Inc., the leader in ... disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized ... Cipher recently announced the completion of the ... every patient is interviewed by a qualified MedAvante mental ...
Cached Medicine Technology:Community-Based Oncology Practices Have a New Affordable Practice Management System Offering by US Oncology 2Community-Based Oncology Practices Have a New Affordable Practice Management System Offering by US Oncology 3Community-Based Oncology Practices Have a New Affordable Practice Management System Offering by US Oncology 4Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 2Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 3
(Date:8/31/2015)... ... August 31, 2015 , ... Now here’s some good health news: Nearly two-thirds ... half your grains whole,” with the majority of Americans eating more whole grains than ... (WGC) released these findings and others from the 2015 Whole Grains Consumer Insights ...
(Date:8/31/2015)... ... 2015 , ... Now through October 31st, the National Ovarian ... on a digital screen projected above New York’s Times Square, on the 1500 ... awareness of the symptoms of ovarian cancer, and earlier conversations with doctors. This ...
(Date:8/31/2015)... ... August 31, 2015 , ... Intellitec Solutions announced they ... bringing on board their 8th new staff member in 2015. With the potential for ... firm. Intellitec Solutions supports Microsoft Dynamics GP, Dynamics SL, Dynamics CRM and Intacct, and ...
(Date:8/31/2015)... ... , ... Adult & Pediatric Dermatology in Greenwood Village, CO has launched a ... and services available to help them. , The website better showcases the practice ... visitors to view the website seamlessly on any desktop computer, tablet or mobile device. ...
(Date:8/31/2015)... ... August 31, 2015 , ... GenHart Software, LLC, a rising ... to help small businesses operate as efficiently and cost effectively as possible, with a ... impact in their first year of operation – and the Charleston business community is ...
Breaking Medicine News(10 mins):Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 3Health News:Intellitec Solutions Achieves Record Pace for New Hiring 2Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 2Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 3Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 3
... Recognize ... Heroes, FORT ... to 19 flight attendants who,have administered emergency medical attention by using onboard,defibrillators. ... Fort Worth to celebrate the lives saved and heroic,measures taken during medical ...
... for Local Economy, METAIRIE, La., April 2, 2008 ... and dental practices,worldwide, produces television advertisements for its more ... production of those ads came home to,New Orleans., ... New Orleans, not only,because of the prime locations for ...
... speed up recovery after fractures and breaks simply by removing ... rats suggests that the technique could kick-start rapid self-healing in ... a bone growth hormone., Agnes Vignerys team at Yale University ... thigh-bone of each animal before syringing out the bone marrow. ...
... 2, 2008 Anthem Blue Cross,announced today process ... year. The changes will include reimbursement modifications and ... by the Centers,for Medicare and Medicaid Services (CMS) ... Anthem Blue Cross,s eight million members from,additional payments ...
... The National,Association of Realtors(R) joined U.S. Senators Richard ... Norm Coleman, R-Minn.,as they introduced the Small Business ... program but reiterates the importance of,reforming the U.S. ... A recently conducted 2008 NAR Health Insurance ...
... -- A patient,s willingness to participate in a clinical trial ... interests in the study, unless the amount of money a ... trial, according to a new study by researchers at the ... Johns Hopkins Berman Institute of Bioethics. , We found ...
Cached Medicine News:Health News:American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony 2Health News:OrthoSynetics(TM) Brings Ad Production Home to New Orleans 2Health News:Bones mend faster without marrow 2Health News:Anthem Blue Cross Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members' Health and Finances by Not Reimbursing Major Preventable Adverse Events 2Health News:Anthem Blue Cross Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members' Health and Finances by Not Reimbursing Major Preventable Adverse Events 3Health News:U.S. Health Care System Must Be Reformed, Say Nine Out of 10 Realtors(R) 2Health News:Knowing doctor's financial interests doesn't deter clinical trial participants 2Health News:Knowing doctor's financial interests doesn't deter clinical trial participants 3
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
2 mm tip....
4 mm x 6 mm dissector end with shaft marked at 10 mm, 20 mm, 30 mm from tip. 6 mm wide curved elevator. Round knurled handle....
Medicine Products: